Cencora reorganizes segments; explores strategic alternatives for MWI Animal Health, Profarma, U.S. Consulting Services

Cencora, Inc.

New segments: U.S. Healthcare Solutions, International Healthcare Solutions, and Other.
Other includes MWI Animal Health, Profarma, U.S. Consulting Services, and legacy Pharmalex components under strategic review.
Segment reporting change effective Q1 FY2026; historical segment data in 2025 10-K revised but consolidated financials unchanged.
No updates on events after November 25, 2025; first quarter FY2026 10-Q filed February 4, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.